DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Benzene Hexacarboxylic Acid is an investigational drug.
There have been 4 clinical trials for Benzene Hexacarboxylic Acid. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Puberty, Precocious, Leukemia, Megakaryoblastic, Acute, and Preleukemia. The leading clinical trial sponsors are Eastern Cooperative Oncology Group, National Cancer Institute (NCI), and Meabco A/S.
Recent Clinical Trials for Benzene Hexacarboxylic Acid
|Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty||Uppsala-Örebro Regional Research Council||N/A|
|Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty||Region Örebro County||N/A|
|BP-C1 Monotherapy in Patients With Metastatic Breast Cancer||Meddoc AS||Phase 2|